Summary
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is an autosomal recessive disorder of mitochondrial fatty acid oxidation which is usually diagnosed in infancy or through neonatal screening. In the absence of population screening, adults with undiagnosed MCADD can be expected. This review discusses 14 cases that were identified during adulthood. The mortality of infantile patients is approximately 25% whereas in this adult case series it was shown it to be 50% in acutely presenting patients and 29% in total. Therefore, undiagnosed individuals are at risk of sudden fatal metabolic decompensation with high mortality. This review illustrates the need to consider the possibility of a fatty acid oxidation defect in an adult who presents with unexplained sudden clinical deterioration, particularly if precipitated by fasting or alcohol consumption. A history of unexplained sibling death may also raise the index of suspicion. There also needs to be appropriate clinical support for those patients identified clinically or as a result of family studies (sibling or parent).
Similar content being viewed by others
Abbreviations
- AFLP:
-
acute fatty liver of pregnancy
- CPT I:
-
carnitine palmitoyltransferase I
- CPT II:
-
carnitine palmitoyltransferase II
- HELLP:
-
syndrome of haemolysis, elevated liver enzymes, and low platelets
- LCHAD:
-
long-chain hydroxy-CoA dehydrogenase deficiency
- MADD:
-
multiple acyl-CoA dehydrogenase deficiency
- MCADD:
-
medium chain acyl-CoA dehydrogenase deficiency
- MTP:
-
mitochondrial trifunctional protein deficiency
- VLCAD:
-
very long chain acyl-CoA dehydrogenase deficiency
- VPA:
-
valproate
References
Bergmann DR, Donckerwolcke RA, Duran et al (1994) Rate-dependent distal renal tubular acidosis in carnitine pamitoyltransferase type I deficiency. Pediatr Res 36:582–588
Bergmann DR, Herrero P, Sciacca R et al (2001) Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy. J Inherit Metab Dis 24:657–674
Bodamer OA, Hoffmann GF, Lindner M (2007) Expanded newborn screening in Europe 2007. J Inherit Metab Dis 30:439–444
Bodman M, Smth D, Nyhan WL, Naviaux RK (2001) Medium-chain acyl coenzyme A dehydrogenase deficiency. Occurrence in an infant and his father. Arch Neurol 58:811–814
Boles RG, Boesel C, Rinaldo P. Sudden death beyond SIDS (1996) Pediatric Pathol Lab Med 16:691–693
Bonnet D, Martin D, de Lonlay P et al (1999) Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100:2248–2253
Borrajo GJC (2007) Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis 30:466–481
Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE (2006) Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 107:115–120
Chess DJ, Stanley WC (2008) Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc Res 2008 79(2):269–278. doi:10.1093/cvr/cvn074
Derks TGJ, Jakobs H, Gerding A, Niezen-Koning KE, Reijngoud D-J, Smit GPA (2004) [Deficiency of the fatty-acid oxidising enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in an adult, detected during a neonatal screening programme]. Ned Tijdschr Geneeskd 148(44): 2185–2190. [In Dutch]
Derks TG, Reingould D, Waterham HR, et al (2006) The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. J Pediatr 148:665–670
Donohue TM (2007) Alcohol-induced steatosis in liver cells. World J Gastroenterol 13(7):4974–4978
Duran M, Hofkamp M, Rhead WJ, Saudubray J-M, Wadman SK (1986) Sudden child death and healthly affected family members with medium-chain acyl-Coenzyme A dehydyrogenase deficiency. Pediatrics 78:1052–1057
Feillet F, Steinmann G, Vianey-Saban C et al (2003) Adult presentation of MCAD deficiency revealed by coma and severe arrhythmias. Intensive Care Med 29:1594–1597
Heptinstall LE, Till J, Wraith JE, Besley GTN (1995) Common McaD mutation in a healthy parent of two affected siblings. J Inherit Metab Dis 18:638–639
Ibdah JA, Yang Z, Bennett MJ (2000) Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Genet Metab 71:182–189
Kim CS, Roe CR, Ambrose WW (1990) l-carnitine prevents mitochondrial damage induced by octanoic acid in the rat choroid plexus. Brain Res 536:335–338
Lafolla AK, Thompson RJ Jr, Roe CR (1994) Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 124:409–415
Leonard JV, Dezateux C (2009) Newborn screening for medium chain acyl CoA dehydrogenase deficiency. Arch Dis Child 94:235–238
Longo N, Di San Filippo CA, Pasquali M (2006) Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 142C:77–85
Losty H, Melville-Thomas G, Pollitt R, Davies S (2001) Medium-chain acyl-CoA dehydrogenase deficiency, sudden unexpected death in a 23-year-old woman. J Inherit Metab Dis 24(Suppl 1): 68
Mayell SJ, Edwards L, Reynolds FE et al (2007) Late presentation of medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 30:104
Njolstad PR, Skjeldal OH, Agsteribbe E et al (1997) Valproate and fatal MCAD deficiency. Ped Neurol 16:160–162
Oliver MF (2006) Sudden cardiac death: the lost fatty acid hypothesis. Q J Med 99:701–709
Olpin SE, Allen J, Bonham JR et al (2001) Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis 24:35–42
Padilla CD, Therrell BL (2007) Newborn screening in the Asia Pacific region. J Inherit Metab Dis 30:490–506
Raymond K, Bale AE, Barnes CA et al (1999) Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45 year old woman. Genet Med 1:293–294
Rijlaarsdam RS, Van Spronsen FJ et al (2004) Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence. Pacing Clin Electrophysiol 27:675–675
Roe CR, Coates PM (1995) Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 1501–1534
Ruitenbeek W, Poels PJE, Turnbull DM et al (1995) Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. J Neurol Neurosurg Psychiatry 58:209–214
Saadallah AA, Rashed MS (2007) Newborn screening:experiences in the Middle East and North America. J Inherit Metab Dis 30:482–489
Saito T, Misawa K, Kawata S (2007) Fatty liver and non-alcoholic steatohepatitis. Intern Med 46(2):101–104 (doi:10.2169/internalmedicine.46.1784)
Santos L, Patterson A, Moreea SM, Lippiatt CM, Walter J, Henderson M (2007) Acute liver failure in pregnancy associated with maternal MCAD deficiency. J Inherit Metab Dis 30:103
Schaefer J, Jackson S, Taroni F, Swift P, Turnball DM (1997) Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy. Neurosurg Pyschiatry 62:169–176
Schuck PF, Ceolato PC, Ferreira GC et al (2007) Oxidative stress induction by cis-4-decenoic acid: relevance for MCAD deficiency. Free Radical Res 41:1261–1272
Seddon HR, Green A, Gray RGF, Leonard JV, Pollitt RJ (1995) Regional variations in medium-chain acyl CoA dehydrogenase deficiency. Lancet 345:135–136
Silva MFB, Aires CCP, Luis PBM et al (2008) Valproic acid metabolism and its effect on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis 31:205–216
Soloff LA (1970) Arrhythmias following fatty acid infusions. Am Heart J 80:671–674
Stanley CA, Hale DE, Coates PM et al (1983) Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res 17:877–885
Therrell BL, Adams J (2007) Newborn screening in North America. J Inherit Metab Dis 30:447–465
Touma EH, Charpentier (1992) Medium chain acyl-CoA dehydrogenase deficiency. Arch Dis Child 67:142–145
Tyni T, Paetau A, Strauss AW, Middleton B, Kivela T (2004) Mitochondrial fatty acid β-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 56:744–750
UKCSNS-MCADD (2008) UK Collaborative Study of Newborn Screening for Medium Chain Acyl CoA Dehydrogenase Deficiency (UKCSNS_MCADD): overview and early findings. http://newbornbloodspot.screening.nhs.uk/mcadd_background Accessed 14/09/09
Wanders RJA, Vreken P, Den Boer MEJ, Wilburg FA, van Gennip AH, Ijlst L (1999) Disorders of mitochondrial fatty acyl-CoA β-oxidation. J Inherit Metab Dis 22:442–487
Wang SY, Kannan S, Shay D, Segal S, Datta S, Tsen L (2002) Anesthetic considerations for a patient with compound heterozygous medium-chain acyl-CoA dehydrogenase deficiency. Anesth Analg 94:1595–1597
Wilcken B, Hammond J, Silink M (1994) Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency. Arch Dis Child 70:410–412
Wilhelm GW (2006) Sudden death in a young woman from medium chain acyl-coenzyme A dehydrogenase (MCAD) deficiency. J Emerg Med 30:291–294
Yamada KA, McHowat J, Yan GX et al (1994) Cellular uncoupling induced by accumulation of long-chain acyl-carnitine during ischemia. Circ Res 74:83–95
Yang B-Z, Ding J-H, Zhou C et al (2000) Identification of a novel mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency. Mol Gen Metab 69:259–262
Acknowledgements
The author acknowledges the helpful advice from Dr Simon Olpin in preparing this review and of Dr Brian Shine with the statistics. The author also acknowledges the updates of live cases provided by the relevant authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Michael Bennett
Competing interests: None declared
Rights and permissions
About this article
Cite this article
Lang, T.F. Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD). J Inherit Metab Dis 32, 675–683 (2009). https://doi.org/10.1007/s10545-009-1202-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-009-1202-0